REACH

September 1, 2021
EC Begins Targeted Consultation on Endocrine Disruptors, Will Hold Online Focus Groups in October
March 1, 2021
ECHA Begins Public Consultation on Derogation to the Exclusion Criteria for Creosote
December 16, 2020
Important Changes to Annex II to REACH Come into Force January 1, 2021
July 20, 2020
European Focus on PMT and vPvM Substances Increases
September 18, 2019
EC Proposes REACH Restriction For PVC Articles Containing Lead And Lead Compounds and Other Recent REACH Developments
July 12, 2019
ECHA’s Management Board Supports Efforts To Improve REACH Authorization And Evaluation and Other Recent REACH Developments
June 12, 2019
BoA Issues Landmark Decision In Data Sharing Dispute and Other Recent REACH Developments
January 8, 2019
Forecast for U.S. Federal and International Chemical Regulatory Policy 2019
March 22, 2018
REACH 2018: Registrants that Initiate Laboratory Testing by March 31, 2018, May Be Granted Extension for Complete Dossier Submission
January 4, 2018
Predictions and Outlook for U.S. Federal and International Chemical Regulatory Policy 2018
 1 2 3 >  View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2021 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.